ASXL1 mutation analysis

Lab Test name Contact Comments
CHU Liège - Hemato ASXL1 mutation analysis Dr Frédéric LAMBERT
3ml EDTA anticoagulated bone marrow with > 20% myeloid blasts.

Prognostic marker MDS, AML, CMML and systemic mastocytosis.

Sanger or NGS/MPS sequencing.
AZ St-Jan Brugge - Laboratoriumgeneeskunde ASXL1 mutation analysis dr. Helena Devos/Friedel Nollet, Ph.D.
Method : Sanger sequencing of ASXL1 gene (exon-12, p.Ile574 to p.Leu743)
Version date: 04/11/2017
Accredited: